Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Radiotherapy planning software:

This article was originally published in Clinica

Executive Summary

MDS Nordion's Helax-TMS V5.0 treatment planning software with segmented intensity modulated radiation therapy (IMRT) has received 510(k) clearance from the US FDA. The Canadian company's radiotherapy planning procedure is particularly effective for head, neck and prostate cancers which are difficult to treat with current technology without damaging surrounding healthy tissue. The software is able to do inverse planning, a tool provided to create plans intended for IMRT treatment delivery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073078

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel